238 related articles for article (PubMed ID: 31655825)
1. Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder.
Liang J; Liu J; Fan R; Chen Z; Chen X; Tong J; Chen Y; Peng F; Jiang Y
Neuroimmunomodulation; 2019; 26(5):258-264. PubMed ID: 31655825
[TBL] [Abstract][Full Text] [Related]
2. The complement and immunoglobulin levels in NMO patients.
Chen Y; Li R; Wu AM; Shu YQ; Lu ZQ; Hu XQ
Neurol Sci; 2014 Feb; 35(2):215-20. PubMed ID: 23881468
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders.
Yoshikura N; Kimura A; Hayashi Y; Inuzuka T
J Neuroimmunol; 2017 Sep; 310():150-157. PubMed ID: 28756870
[TBL] [Abstract][Full Text] [Related]
4. C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
Pache F; Ringelstein M; Aktas O; Kleiter I; Jarius S; Siebert N; Bellmann-Strobl J; Paul F; Ruprecht K
J Neuroimmunol; 2021 Nov; 360():577699. PubMed ID: 34464830
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
6. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
7. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.
Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W
Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity.
Song Y; Zhu M; Liu C; Zheng C; Zhou Y; Zhu J; Jin T
Immunobiology; 2019 May; 224(3):397-401. PubMed ID: 30852049
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Changes in AQP4-IgG Level and Immunological Markers During Protein-A Immunoadsorption Therapy for NMOSD: A Case Report and Literature Review.
Chen B; Qin C; Chen M; Yu HH; Tao R; Chu YH; Bu BT; Tian DS
Front Immunol; 2021; 12():650782. PubMed ID: 34367127
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy.
Wang Y; Wu A; Chen X; Zhang L; Lin Y; Sun S; Cai W; Zhang B; Kang Z; Qiu W; Hu X; Lu Z
BMC Neurol; 2014 Dec; 14():246. PubMed ID: 25526927
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
13. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
14. Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.
Tong Y; Wang L; Liu K; Liu W; Li S; Song B; Xia Z; Xu Y; Zhang R
Curr Neurovasc Res; 2021; 18(2):227-236. PubMed ID: 34225621
[TBL] [Abstract][Full Text] [Related]
15. Association of Circulating Follicular Helper T Cells and Serum CXCL13 With Neuromyelitis Optica Spectrum Disorders.
Yang X; Peng J; Huang X; Liu P; Li J; Pan J; Wei Z; Liu J; Chen M; Liu H
Front Immunol; 2021; 12():677190. PubMed ID: 34335576
[TBL] [Abstract][Full Text] [Related]
16. Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder.
Kimura A; Takemura M; Saito K; Serrero G; Yoshikura N; Hayashi Y; Inuzuka T
J Neuroimmunol; 2017 Apr; 305():175-181. PubMed ID: 28100408
[TBL] [Abstract][Full Text] [Related]
17. Low high-density lipoprotein cholesterol and high triglycerides lipid profile in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Cho EB; Cho HJ; Choi M; Seok JM; Shin HY; Kim BJ; Min JH
Mult Scler Relat Disord; 2020 May; 40():101981. PubMed ID: 32045867
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.
Yamashita K; Kinoshita M; Miyamoto K; Namba A; Shimizu M; Koda T; Sugimoto T; Mori Y; Yoshioka Y; Nakatsuji Y; Kumanogoh A; Kusunoki S; Mochizuki H; Okuno T
J Neuroinflammation; 2018 Apr; 15(1):125. PubMed ID: 29703264
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder.
Uzonyi B; Szabó Z; Trojnár E; Hyvärinen S; Uray K; Nielsen HH; Erdei A; Jokiranta TS; Prohászka Z; Illes Z; Józsi M
Front Immunol; 2021; 12():660382. PubMed ID: 33986750
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
